Cristina López Selected Research

Cristina López Research Topics

Disease

9	Neoplasms (Cancer) 04/2024 - 09/2015
8	Lymphoma (Lymphomas) 04/2024 - 09/2015
6	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 09/2015
6	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 09/2015
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 11/2015
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 05/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 01/2024
2	Bradycardia 05/2022 - 02/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 12/2008
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 02/2019
2	Infections 10/2004 - 03/2002
1	Genomic Instability 05/2024
1	Opiate Overdose 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Diabetes Complications 05/2022
1	Body Weight (Weight, Body) 03/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Genetic Translocation (Chromosomal Translocation) 12/2021
1	COVID-19 01/2021
1	Leiomyosarcoma 12/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 06/2019
1	Neonatal Abstinence Syndrome 06/2019
1	Pain (Aches) 06/2019
1	Weight Gain 06/2019
1	Circulating Neoplastic Cells 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Immunoglobulin G4-Related Disease 12/2018
1	Trisomy (Trisomies) 01/2016
1	Mastitis 04/2015
1	Residual Neoplasm 05/2014
1	Necrosis 08/2013
1	Latent Tuberculosis 08/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2012
1	Multiple Sclerosis 02/2009
1	Atherosclerotic Plaque (Atheroma) 10/2004

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2009
3	RNA (Ribonucleic Acid)IBA 10/2023 - 09/2015
3	Serotonin (5 Hydroxytryptamine)IBA 05/2022 - 02/2019
3	Fluoxetine (Prozac)FDA LinkGeneric 05/2022 - 02/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2016
3	Immunoglobulin G (IgG)IBA 12/2018 - 03/2002
2	Transcription Factors (Transcription Factor)IBA 04/2024 - 09/2015
2	Complement System Proteins (Complement)IBA 12/2023 - 01/2019
2	Long Noncoding RNAIBA 10/2023 - 09/2015
2	Opioid Analgesics (Opioids)IBA 01/2023 - 06/2019
2	Antidepressive Agents (Antidepressants)IBA 05/2022 - 02/2019
1	NF-kappa B (NF-kB)IBA 05/2024
1	ChromatinIBA 05/2024
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2023
1	Methadone (Dolophine)FDA LinkGeneric 01/2023
1	Naltrexone (ReVia)FDA LinkGeneric 01/2023
1	Cell-Free Nucleic AcidsIBA 06/2022
1	1- (2- (4- (4- fluoro- benzoyl)- piperidin- 1- yl)- ethyl)- 3,3- dimethyl- 1,2- dihydro- indol- 2- oneIBA 05/2022
1	L 694247IBA 05/2022
1	Cholinergic Agents (Cholinergics)IBA 05/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022
1	NitrogenIBA 03/2022
1	Urea (Carbamide)FDA LinkGeneric 03/2022
1	CreatinineIBA 03/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2021
1	Ligases (Synthetase)IBA 12/2021
1	UbiquitinIBA 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2020
1	3-deazaneplanocinIBA 05/2020
1	Histones (Histone)IBA 05/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020
1	nasIBA 06/2019
1	Antirheumatic Agents (DMARD)IBA 12/2018
1	Radium-223IBA 12/2018
1	human MIRN376C microRNAIBA 11/2016
1	human MIRN142 microRNAIBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 11/2015
1	hydrogen sulfite (bisulfite)IBA 11/2015
1	SphingosineIBA 11/2015
1	Carrier Proteins (Binding Protein)IBA 09/2015
1	EnrofloxacinIBA 04/2015
1	GoldIBA 08/2013
1	Tuberculin (PPD)IBA 08/2013
1	Dacarbazine (DIC)FDA LinkGeneric 03/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	Interferon-betaIBA 02/2009
1	LipidsIBA 12/2008
1	Bacterial DNAIBA 10/2004
1	UreaseIBA 03/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 02/2009
1	Drug Therapy (Chemotherapy) 12/2022
1	Polypharmacy 01/2022
1	Secondary Prevention 10/2019
1	Length of Stay 06/2019
1	Castration 12/2018